Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 133

1.

Risk of Bias in Study of Varenicline and Cardiovascular Outcomes.

Goulden R, Nguyen QD, Azoulay L.

Am J Respir Crit Care Med. 2018 Apr 30. doi: 10.1164/rccm.201803-0423LE. [Epub ahead of print] No abstract available.

PMID:
29708402
2.

Dipeptidyl peptidase-4 inhibitors and incidence of inflammatory bowel disease among patients with type 2 diabetes: population based cohort study.

Abrahami D, Douros A, Yin H, Yu OHY, Renoux C, Bitton A, Azoulay L.

BMJ. 2018 Mar 21;360:k872. doi: 10.1136/bmj.k872.

3.

Non-Vitamin K Antagonist Oral Anticoagulants and Risk of Serious Liver Injury.

Douros A, Azoulay L, Yin H, Suissa S, Renoux C.

J Am Coll Cardiol. 2018 Mar 13;71(10):1105-1113. doi: 10.1016/j.jacc.2018.01.009.

PMID:
29519351
4.

The Risk for Lung Cancer Incidence with Calcium Channel Blockers: A Systematic Review and Meta-Analysis of Observational Studies.

Rotshild V, Azoulay L, Zarifeh M, Masarwa R, Hirsh-Raccah B, Perlman A, Muszkat M, Matok I.

Drug Saf. 2018 Jun;41(6):555-564. doi: 10.1007/s40264-018-0644-4.

PMID:
29484611
5.

SGLT-2 inhibitors and the risk of infections: a systematic review and meta-analysis of randomized controlled trials.

Puckrin R, Saltiel MP, Reynier P, Azoulay L, Yu OHY, Filion KB.

Acta Diabetol. 2018 May;55(5):503-514. doi: 10.1007/s00592-018-1116-0. Epub 2018 Feb 27. Review.

PMID:
29484489
6.

Reply to P. Autier et al.

Suissa S, Azoulay L.

J Clin Oncol. 2018 Mar 10;36(8):831-832. doi: 10.1200/JCO.2017.77.0057. Epub 2018 Jan 25. No abstract available.

PMID:
29369706
7.

Aromatase inhibitors and the risk of colorectal cancer in postmenopausal women with breast cancer.

Khosrow-Khavar F, Yin H, Barkun A, Bouganim N, Azoulay L.

Ann Oncol. 2018 Mar 1;29(3):744-748. doi: 10.1093/annonc/mdx822.

PMID:
29293897
8.

Incretin-based Drugs and the Incidence of Colorectal Cancer in Patients with Type 2 Diabetes.

Abrahami D, Yin H, Yu OHY, Pollak MN, Azoulay L.

Epidemiology. 2018 Mar;29(2):246-253. doi: 10.1097/EDE.0000000000000793.

PMID:
29283894
9.

Testosterone replacement therapy and the risk of stroke in men: A systematic review.

Loo SY, Chen BY, Yu OHY, Azoulay L, Renoux C.

Maturitas. 2017 Dec;106:31-37. doi: 10.1016/j.maturitas.2017.08.013. Epub 2017 Sep 1. Review.

PMID:
29150164
10.

Crowd vocal learning induces vocal dialects in bats: Playback of conspecifics shapes fundamental frequency usage by pups.

Prat Y, Azoulay L, Dor R, Yovel Y.

PLoS Biol. 2017 Oct 31;15(10):e2002556. doi: 10.1371/journal.pbio.2002556. eCollection 2017 Oct.

11.

Sulfonylureas as Initial Treatment for Type 2 Diabetes and the Risk of Severe Hypoglycemia.

Yu O, Azoulay L, Yin H, Filion KB, Suissa S.

Am J Med. 2018 Mar;131(3):317.e11-317.e22. doi: 10.1016/j.amjmed.2017.09.044. Epub 2017 Oct 12.

PMID:
29032229
12.

Long-Term Use of Long-Acting Insulin Analogs and Breast Cancer Incidence in Women With Type 2 Diabetes.

Wu JW, Azoulay L, Majdan A, Boivin JF, Pollak M, Suissa S.

J Clin Oncol. 2017 Nov 10;35(32):3647-3653. doi: 10.1200/JCO.2017.73.4491. Epub 2017 Sep 27.

PMID:
28953430
13.

Pharmacologic Differences of Sulfonylureas and the Risk of Adverse Cardiovascular and Hypoglycemic Events.

Douros A, Yin H, Yu OHY, Filion KB, Azoulay L, Suissa S.

Diabetes Care. 2017 Nov;40(11):1506-1513. doi: 10.2337/dc17-0595. Epub 2017 Sep 1.

PMID:
28864502
14.

Thiazolidinedione drugs in the treatment of type 2 diabetes mellitus: past, present and future.

Davidson MA, Mattison DR, Azoulay L, Krewski D.

Crit Rev Toxicol. 2018 Jan;48(1):52-108. doi: 10.1080/10408444.2017.1351420. Epub 2017 Aug 17.

PMID:
28816105
15.

Androgen Deprivation Therapy and the Risk of Anemia in Men with Prostate Cancer.

Hicks BM, Klil-Drori AJ, Yin H, Campeau L, Azoulay L.

Epidemiology. 2017 Sep;28(5):712-718. doi: 10.1097/EDE.0000000000000678.

PMID:
28768300
16.

A Combination of Testosterone and White Blood Cell Count as a Predictive Factor of Overall Survival in Localized Prostate Cancer.

Taussky D, Souliéres D, Azoulay L, Yin H, Bahig H, Bahary JP, Delouya G.

Target Oncol. 2017 Oct;12(5):695-701. doi: 10.1007/s11523-017-0516-3.

PMID:
28712059
17.

Early switch to second-line tyrosine kinase inhibitor in chronic myeloid leukemia patients failing to achieve early molecular response.

Klil-Drori AJ, Yin H, Azoulay L, Harnois M, Gratton MO, Del Corpo A, Olney HJ, Delage R, Laneuville P, Mollica L, Busque L, Assouline SE; Quebec CML Group.

Am J Hematol. 2017 Oct;92(10):E602-E604. doi: 10.1002/ajh.24838. Epub 2017 Jul 29. No abstract available.

PMID:
28670773
18.

Postoperative Pelvic Radiotherapy in Patients With Endometrial Cancer May Increase the Risk for Secondary Pelvic Cancers: A Post Hoc Analysis of Results From the TME, PORTEC-1, and PORTEC-2 Trials.

Wissing MD, Azoulay L.

J Clin Oncol. 2017 Jun 1;35(16):1861-1862. doi: 10.1200/JCO.2017.72.6497. Epub 2017 Mar 13. No abstract available.

PMID:
28549230
19.

Comparing Clinical Characteristics and Outcomes of Young-onset and Late-onset Colorectal Cancer: An International Collaborative Study.

Rho YS, Gilabert M, Polom K, Aladashvili A, Kopeckova K, Megdanova V, Coleman N, Greally M, Marrelli D, Roviello F, McDermott R, Petrova V, Mihaylova Z, Bortlicek Z, Prausova J, Batist G, Azoulay L, Kavan P.

Clin Colorectal Cancer. 2017 Dec;16(4):334-342. doi: 10.1016/j.clcc.2017.03.008. Epub 2017 Mar 21.

PMID:
28462853
20.

Sulfonylureas and the Risks of Cardiovascular Events and Death: A Methodological Meta-Regression Analysis of the Observational Studies.

Azoulay L, Suissa S.

Diabetes Care. 2017 May;40(5):706-714. doi: 10.2337/dc16-1943. Review.

PMID:
28428321
21.

Metformin and the incidence of viral associated cancers in patients with type 2 diabetes.

Hicks BM, Yin H, Sinyavskaya L, Suissa S, Azoulay L, Brassard P.

Int J Cancer. 2017 Jul 1;141(1):121-128. doi: 10.1002/ijc.30733. Epub 2017 Apr 24.

22.

Prolactin-Elevating Antipsychotics and the Risk of Endometrial Cancer.

Klil-Drori AJ, Yin H, Abenhaim HA, du Fort GG, Azoulay L.

J Clin Psychiatry. 2017 Jun;78(6):714-719. doi: 10.4088/JCP.15m10532.

PMID:
28199787
23.

A population-based study of chronic hepatitis C in immigrants and non-immigrants in Quebec, Canada.

Greenaway C, Azoulay L, Allard R, Cox J, Tran VA, Abou Chakra CN, Steele R, Klein M.

BMC Infect Dis. 2017 Feb 13;17(1):140. doi: 10.1186/s12879-017-2242-y.

24.

Cardiotoxicity of aromatase inhibitors and tamoxifen in postmenopausal women with breast cancer: a systematic review and meta-analysis of randomized controlled trials.

Khosrow-Khavar F, Filion KB, Al-Qurashi S, Torabi N, Bouganim N, Suissa S, Azoulay L.

Ann Oncol. 2017 Mar 1;28(3):487-496. doi: 10.1093/annonc/mdw673. Review.

25.

Androgen deprivation therapy for prostate cancer and the risk of hospitalisation for community-acquired pneumonia.

Hicks BM, Yin H, Bladou F, Ernst P, Azoulay L.

Thorax. 2017 Jul;72(7):596-597. doi: 10.1136/thoraxjnl-2016-209512. Epub 2016 Dec 16.

PMID:
27986803
26.

Androgen Deprivation Therapy and the Risk of Dementia in Patients With Prostate Cancer.

Khosrow-Khavar F, Rej S, Yin H, Aprikian A, Azoulay L.

J Clin Oncol. 2017 Jan 10;35(2):201-207. Epub 2016 Nov 21.

PMID:
27870566
27.

The use of drugs acting on the renin-angiotensin system and the incidence of pancreatic cancer.

Mandilaras V, Bouganim N, Yin H, Asselah J, Azoulay L.

Br J Cancer. 2017 Jan 3;116(1):103-108. doi: 10.1038/bjc.2016.375. Epub 2016 Nov 15.

28.

Cancer, obesity, diabetes, and antidiabetic drugs: is the fog clearing?

Klil-Drori AJ, Azoulay L, Pollak MN.

Nat Rev Clin Oncol. 2017 Feb;14(2):85-99. doi: 10.1038/nrclinonc.2016.120. Epub 2016 Aug 9. Review.

PMID:
27502359
29.
31.

The Use of Telmisartan and the Incidence of Cancer.

Tascilar K, Azoulay L, Dell'Aniello S, Bartels DB, Suissa S.

Am J Hypertens. 2016 Dec 1;29(12):1358-1365. doi: 10.1093/ajh/hpw095.

32.

Hospitalizations in Immigrants and Nonimmigrants Diagnosed With Chronic Hepatitis C Infection in Québec.

Kamstra R, Azoulay L, Steele R, Klein MB, Greenaway C.

Clin Infect Dis. 2016 Dec 1;63(11):1439-1448. Epub 2016 Aug 7.

PMID:
27501843
33.

Association Between Incretin-Based Drugs and the Risk of Acute Pancreatitis.

Azoulay L, Filion KB, Platt RW, Dahl M, Dormuth CR, Clemens KK, Durand M, Hu N, Juurlink DN, Paterson JM, Targownik LE, Turin TC, Ernst P; and the Canadian Network for Observational Drug Effect Studies (CNODES) Investigators, Suissa S, Dormuth CR, Hemmelgarn BR, Teare GF, Caetano P, Chateau D, Henry DA, Paterson JM, LeLorier J, Levy AR, Ernst P, Platt RW, Sketris IS.

JAMA Intern Med. 2016 Oct 1;176(10):1464-1473. doi: 10.1001/jamainternmed.2016.1522.

PMID:
27479930
34.

Association of Bile Duct and Gallbladder Diseases With the Use of Incretin-Based Drugs in Patients With Type 2 Diabetes Mellitus.

Faillie JL, Yu OH, Yin H, Hillaire-Buys D, Barkun A, Azoulay L.

JAMA Intern Med. 2016 Oct 1;176(10):1474-1481. doi: 10.1001/jamainternmed.2016.1531.

PMID:
27478902
35.

Authors' reply to Gallagher and Winocour.

Azoulay L, Filion KB.

BMJ. 2016 Jul 6;354:i3668. doi: 10.1136/bmj.i3668. No abstract available.

PMID:
27384422
36.

Statin Use in Patients With Hepatitis C-related Cirrhosis: True Benefit or Immortal Time Bias?

Shin JY, Azoulay L, Filion KB.

Gastroenterology. 2016 Aug;151(2):373. doi: 10.1053/j.gastro.2015.11.055. Epub 2016 Jul 1. No abstract available.

PMID:
27376527
37.

Androgen Deprivation Therapy and the Incidence of Inflammatory Bowel Disease in Patients With Prostate Cancer.

Klil-Drori AJ, Tascilar K, Yin H, Aprikian A, Bitton A, Azoulay L.

Am J Epidemiol. 2016 Jul 1;184(1):15-22. doi: 10.1093/aje/kwv307. Epub 2016 Jun 6.

38.

Phosphodiesterase Type 5 Inhibitors and the Risk of Melanoma Skin Cancer.

Lian Y, Yin H, Pollak MN, Carrier S, Platt RW, Suissa S, Azoulay L.

Eur Urol. 2016 Nov;70(5):808-815. doi: 10.1016/j.eururo.2016.04.035. Epub 2016 May 10.

PMID:
27178449
39.

Cardiovascular Safety Warnings and the Prescribing of Varenicline: An Interrupted Time-series Analysis.

Filion KB, Eberg M, Azoulay L.

Epidemiology. 2016 Jul;27(4):e28-9. doi: 10.1097/EDE.0000000000000492. No abstract available.

PMID:
27046129
40.

Use of Calcium Channel Blockers and Risk of Breast Cancer: A Population-based Cohort Study.

Azoulay L, Soldera S, Yin H, Bouganim N.

Epidemiology. 2016 Jul;27(4):594-601. doi: 10.1097/EDE.0000000000000483.

PMID:
27031042
41.

Pioglitazone use and risk of bladder cancer: population based cohort study.

Tuccori M, Filion KB, Yin H, Yu OH, Platt RW, Azoulay L.

BMJ. 2016 Mar 30;352:i1541. doi: 10.1136/bmj.i1541.

42.

A Multicenter Observational Study of Incretin-based Drugs and Heart Failure.

Filion KB, Azoulay L, Platt RW, Dahl M, Dormuth CR, Clemens KK, Hu N, Paterson JM, Targownik L, Turin TC, Udell JA, Ernst P; CNODES Investigators.

N Engl J Med. 2016 Mar 24;374(12):1145-54. doi: 10.1056/NEJMoa1506115.

43.

Incretin based drugs and the risk of pancreatic cancer: international multicentre cohort study.

Azoulay L, Filion KB, Platt RW, Dahl M, Dormuth CR, Clemens KK, Durand M, Juurlink DN, Targownik LE, Turin TC, Paterson JM, Ernst P; Canadian Network for Observational Drug Effect Studies Investigators.

BMJ. 2016 Feb 17;352:i581. doi: 10.1136/bmj.i581.

44.

Use of statins and reduced risk of recurrence of VTE in an older population. A population-based cohort study.

Tagalakis V, Eberg M, Kahn S, Azoulay L.

Thromb Haemost. 2016 Jun 2;115(6):1220-8. doi: 10.1160/TH15-10-0775. Epub 2016 Jan 28.

PMID:
26819144
45.

The Association Between Bleeding and the Incidence of Warfarin Discontinuation in Patients with Atrial Fibrillation.

Simon TA, Pan X, Kawabata H, Huang HY, Azoulay L.

Cardiovasc Ther. 2016 Apr;34(2):94-9. doi: 10.1111/1755-5922.12174.

46.

Effect of Long-Acting Insulin Analogs on the Risk of Cancer: A Systematic Review of Observational Studies.

Wu JW, Filion KB, Azoulay L, Doll MK, Suissa S.

Diabetes Care. 2016 Mar;39(3):486-94. doi: 10.2337/dc15-1816. Epub 2016 Jan 6. Review.

PMID:
26740633
47.

RE: Aspirin, Ibuprofen, and the Risk for Colorectal Cancer in Lynch Syndrome.

Tuccori M, Filion KB, Azoulay L.

J Natl Cancer Inst. 2015 Dec 27;108(2). pii: djv384. doi: 10.1093/jnci/djv384. Print 2016 Feb. No abstract available.

PMID:
26711870
48.

The Use of Glyburide Compared With Other Sulfonylureas and the Risk of Cancer in Patients With Type 2 Diabetes.

Tuccori M, Wu JW, Yin H, Majdan A, Azoulay L.

Diabetes Care. 2015 Nov;38(11):2083-9. doi: 10.2337/dc15-1358. Epub 2015 Sep 4.

PMID:
26341130
49.

Threshold levels of visual field and acuity loss related to significant decreases in the quality of life and emotional states of patients with retinitis pigmentosa.

Azoulay L, Chaumet-Riffaud P, Jaron S, Roux C, Sancho S, Berdugo N, Audo I, Sahel JA, Mohand-Saïd S.

Ophthalmic Res. 2015;54(2):78-84. doi: 10.1159/000435886. Epub 2015 Jul 29.

50.

5α-Reductase Inhibitors and the Risk of Cancer-Related Mortality in Men With Prostate Cancer.

Azoulay L, Eberg M, Benayoun S, Pollak M.

JAMA Oncol. 2015 Jun;1(3):314-20. doi: 10.1001/jamaoncol.2015.0387.

PMID:
26181177

Supplemental Content

Loading ...
Support Center